Pharmaniaga perlu pembaharuan selepas diklasifikasi PN17, kata kumpulan
Syarikat farmaseutikal berkaitan kerajaan Pharmaniaga Bhd diklasifikasikan sebagai syarikat bermasalah di bawah PN17 selepas dilabel menghadapi masalah kewangan pada Bursa Malaysia.– Gambar fail The Malaysian Insight, 1 Mac, 2023.
TERDAPAT keperluan mendesak untuk pembaharuan diperkenalkan, khususnya mengenai amalan perolehan ubat-ubatan sektor awam selepas Pharmaniaga Bhd dikeluarkan Nota Amalan 17 , kata Galen Centre for Health and Social Policy. Ketua Pegawai Eksekutifnya Azrul Mohd Khalib berkata klasifikasi Pharmaniaga sebagai syarikat yang mengalami masalah kewangan mewakili panggilan untuk sektor farmaseutikal.
Bermula July 2018, akses bagi laporan penuh hanya untuk anda yang melanggan. Daftar sekarang dan nikmati satu minggu akses percuma!
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pharmaniaga now a PN17 company | The Malaysian InsightBursa Malaysia labels firm financially distressed.
Read more »
Pharmaniaga needs reforms after PN17 classification, says health group | The Malaysian InsightGalen Centre says situation could have severe implications across the pharma industry landscape.
Read more »
Pharmaniaga is now a PN17 companyPETALING JAYA: Pharmaniaga Bhd has been classified as an affected listed issuer under Practice Note 17 (PN17) of the Main Market Listing Requirements of Bursa Malaysia.
Read more »
Pharmaniaga falls under PN17Revenue tumbled 27.1 per cent to RM3.51 billion from RM4.82 billion as there was lower demand from the government for the purchase of Covid-19 vaccines. theSun theSundaily Pharmaniaga loss revenue vaccine FinancialCrisis
Read more »
Pharmaniaga shares down 43pc to 25 sen after PN17 classificationKUALA LUMPUR, Feb 28 — Pharmaniaga Bhd shares fell 43 per cent after the company’s RM552.3 million provision for “slow-moving inventories of Covid-19 vaccines” dragged...
Read more »
Bursa Malaysia umum Pharmaniaga syarikat PN17Sehingga 28 Februari 2023, 29 syarikat di bawah PN17 dan GN3 yang mewakili 3.05 peratus daripada jumlah keseluruhan 950 syarikat tersenarai
Read more »